MetLife, Inc. (NYSE:MET) has been given an average recommendation of “Buy” by the twenty-three analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, ten have given a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $58.29.

Several research analysts recently issued reports on MET shares. BidaskClub upgraded shares of MetLife from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Zacks Investment Research downgraded shares of MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. ValuEngine upgraded shares of MetLife from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 26th. Argus reduced their price target on shares of MetLife from $60.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, August 9th. Finally, Langen Mcalenn reiterated a “buy” rating on shares of MetLife in a research report on Wednesday, August 16th.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/11/24/brokerages-set-metlife-inc-met-pt-at-58-29.html.

In other MetLife news, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the transaction, the insider now directly owns 49,660 shares in the company, valued at approximately $2,711,436. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now owns 25,181 shares in the company, valued at $1,367,076.49. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Prudential Financial Inc. raised its position in shares of MetLife by 71.4% in the 2nd quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock valued at $201,778,000 after acquiring an additional 1,529,570 shares during the period. Schwab Charles Investment Management Inc. raised its position in shares of MetLife by 5.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,555,656 shares of the financial services provider’s stock valued at $195,348,000 after acquiring an additional 175,311 shares during the period. PGGM Investments raised its position in shares of MetLife by 2.3% in the 3rd quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock valued at $29,972,000 after acquiring an additional 12,978 shares during the period. KBC Group NV raised its position in shares of MetLife by 14.3% in the 2nd quarter. KBC Group NV now owns 1,263,802 shares of the financial services provider’s stock valued at $69,433,000 after acquiring an additional 157,734 shares during the period. Finally, Rockefeller Financial Services Inc. raised its position in shares of MetLife by 189.7% in the 3rd quarter. Rockefeller Financial Services Inc. now owns 37,153 shares of the financial services provider’s stock valued at $1,930,000 after acquiring an additional 24,330 shares during the period. Institutional investors own 75.85% of the company’s stock.

MetLife (MET) traded up $0.12 on Tuesday, hitting $51.83. 1,303,105 shares of the stock traded hands, compared to its average volume of 5,786,647. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. MetLife has a fifty-two week low of $44.26 and a fifty-two week high of $55.91. The company has a market cap of $54,414.38, a price-to-earnings ratio of 9.94, a price-to-earnings-growth ratio of 1.30 and a beta of 1.51.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.19. MetLife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The business had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. During the same quarter in the prior year, the firm earned $1.28 EPS. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. sell-side analysts predict that MetLife will post 4.43 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Shareholders of record on Monday, November 6th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, November 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 3.09%. MetLife’s payout ratio is presently -320.00%.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.